21autumn speaker

PREGENE to Participate at ACCESS CHINA Biotech Forum

By Yafo Life Science

September 18th, 2021 (Shanghai) — We are glad to announce that Jing Wang, Board Secretary of PREGENE, has been invited to showcase at ACCESS CHINA Biotech Forum onThursday, September 23, 2021 at 9:00 p.m. ET. ACCESS CHINA Biotech Forum is the largest online corporate access event between China and the western biopharma industry.

If you are interested in listening to the live event, please register at https://biotochina.org/register/

About PREGENE

Shenzhen PREGENE biopharmaceutical Co., Ltd. is a leading enterprise in the research and development of cell and gene therapy drugs with industrialized core technology. The company’s product line includes CAR-T and CAR-NK for hematoma, TCR-T for solid tumor, and stem cell drugs for bone injury. Among them, CAR-T cell drugs for the treatment of multiple myeloma have obtained NMPA clinical approval as class I new drugs, and have been authorized in India, South Korea and other international markets.

The company is a national high-tech enterprise and a participant in the formulation of cell drug quality standards in China. The company has built a small-scale and pilot scale-up system of new biological drugs such as gene editing platform, virus and cell large-scale preparation platform and nano antibody screening platform. The total laboratory area is about 10000 square meters, and has completed a series of process development of cutting-edge projects such as general CAR-T, double target CAR-T, TCR-T and mRNA.

About ACCESS CHINA

ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. View more information at https://biotochina.org/access-china-forum/

ACCESS CHINA Upcoming event

ACCESS CHINA Biotech Forum @ The 16th China Pharma & MedTech BD Forum” will be held in Suzhou and online on September 23rd-30th, 2021. This conference is the largest ACCESS CHINA event of the year.


Contact US

Register ACCESS CHINA online, please visit:

ACCESS CHINA Biotech Forum

For more information, please contact:

Wendi Xiang

Wxiang@yafocapital.com